Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
#Expert Research: Can CBD effectively impede growth of heterotopic lung cancer?
Lung cancer is the most chronic form of cancer and the leading cause of cancer mortality in the world, according to studies by the American Lung Association. Despite recent advances in medical oncology, metastatic lung cancer remains incurable; however, a new discovery by Augusta University researchers has brought new hope to tackling the illness. That discovery, which stems from a joint preclinic study conducted by scientists from the Dental College of Georgia and the Medical College of Georgia at Augusta University and Medicinal Cannabis of Georgia, LLC, was published in the May 2023 issue of Human Cell. The study was led by Babak Baban, PhD, associate dean of research, immunologist and professor at DCG and one of the founders of Medicinal Cannabis of Georgia, an Augusta-based biomedical research and developmental company. The study revealed for the first time that inhalant cannabidiol, commonly referred to as CBD, can effectively impede growth of heterotopic lung cancer. “The central core of our research has been studying inflammatory diseases and for that we picked two different directions: one is centered around chronic inflammation in our system and the other is neurologic diseases such as dementia. Because of their impressive anti-inflammation effects, CBD, CBC and other cannabinoids have attracted our attention,” Baban said. “We have had some exciting findings before, and based on those, we built a new model of lung cancer. This is the first time the effect of the CBD has been assessed in inhalant format using an inhaler. This makes it more translatable into humans and more accurate,” he said. “Obviously, we are just as excited about our discoveries on mechanisms by which CBD worked. They help advance our understanding of the pathophysiology of lung cancer. We have seen some effects on plasticity and cancer stem cells, which appear to be crucial for tumors to regenerate and renew themselves.” Unlike most anti-angiogenesis drugs, inhalant CBD at the experimental dosage did not show any detectable side effects or toxicity. The findings support the notion that inhalant CBD has enough beneficial effects as a viable complementary modality to be included in combination with current standard treatments for lung cancer. Additionally, inhalant CBD delivered using a precisely metered dose is non-invasive, and has high translational value, warranting further research through clinical trials for lung cancer and possibly some other malignancies. “The cannabis plant has over 113 cannabinoids, two of which are very famous: THC and cannabidiol, or CBD. We have conducted extensive research on medicinal cannabis since 2014, but cannabis has been utilized for medicinal purposes for over 1,000 years,” Baban said. “It is not until recently we have started understanding a little better mechanisms how cannabidiols like CBD work.” Babak Baban is a professor, immunologist and associate dean for research at the Dental College of Georgia at Augusta University where he has served for 13 of his 20 years as a translational and clinical immunologist. Babak is available to speak to media about this important topic - simply click on his icon now to arrange a time to speak today.
Nicholas Petrelli, M.D., Receives Lifetime Achievement Award
Nicholas Petrelli, M.D., Bank of America Endowed Medical Director of ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, has received the Lifetime Achievement Award from Tulane University School of Medicine in New Orleans, Louisiana. Petrelli is a 1973 graduate of the school. Dr. Petrelli, center, receives the Lifetime Achievement Award from Julius L. Levy, Jr., M.D., past president, Tulane Medical Alumni Association, left, and Lee Hamm, M.D., senior vice president & dean of the School of Medicine, and the James R. Doty Distinguished Professor and Chair, Tulane University School of Medicine, New Orleans, Louisiana. The award recognizes an alumnus of the school who has made significant contributions to the field of medicine and has offered outstanding leadership in the community. Under Petrelli’s leadership at ChristianaCare since 2001, the Helen F. Graham Cancer Center & Research Institute has become a national model for multidisciplinary cancer care and a top enroller in U.S. clinical research trials. The Graham Cancer Center is a National Cancer Institute Community Oncology Research Program and one of only five hybrid academic community cancer centers in the nation. Through the work of the Graham Cancer Center and partnerships with health care providers, community organizations and the state to improve the prevention, diagnosis and treatment of cancer, Delaware’s cancer mortality rate has dropped twice as fast as the national rate. In addition, the state is outpacing the nation in reducing deaths from a number of cancers. Delaware has gone from number one in cancer mortality 22 years ago to number 17 today. Petrelli has numerous achievements in cancer care and research. He has established several firsts for Delaware, including a multidisciplinary disease center site, the Cawley Center for Translational Cancer Research, a tissue procurement center, an adult genetic counseling program, a statewide high-risk family cancer registry consisting of more than 500,000 individuals and an innovative oncology express unit to provide patients with cancer a way to address urgent care needs without having to go to the emergency department. Among his accomplishments on the national level are the first primary care practice established at a cancer center and the first gene editing research program integrated into a community cancer center. Through a unique research partnership with the Ellen and Ronald Caplan Cancer Center of The Wistar Institute, he has brought cutting-edge cancer treatments and diagnostics to Delawareans. And in a ground-breaking collaboration among the government, community organizations and the Graham Cancer Center nearly 10 years ago, Delaware ended the disparity between Black and white people for colorectal cancer screenings and mortality, which continues to this day. Petrelli has received numerous awards and has authored 360 peer-reviewed manuscripts and 31 book chapters. He has served on advisory panels of the National Cancer Institute, the American Society of Clinical Oncology, the American Cancer Society and the Society of Surgical Oncology. He was president of the Society of Surgical Oncology from 2007 to 2008. In 2013 he received the Order of the First State Award, the highest honor in the state, from Delaware Gov. Jack Markell. In 2019 he received the James Tilton award (named for the first U.S. Army Surgeon General) from the Medical Society of Delaware.
New Policy on BMI Use Will Change How Physicians Approach Diagnoses and Care
The Body Mass Index – or BMI – table was created in the mid-1800s, and for the last several decades has been viewed as the choice tool to diagnose obesity. However, the American Medical Association (AMA) recently issued a policy clarifying the role of BMI after taking a comprehensive look at both its benefits and limitations as a diagnostic tool. In short, the new policy urges physicians to use BMI only in conjunction with other measures of risk and recognizes the historical shortcomings of the oft-used formula. Lisa Diewald, MS, RDN, LDN, is the program manager of the MacDonald Center for Nutrition Education and Research with Villanova’s M. Louise Fitzpatrick College of Nursing. She applauds the AMA for embracing a more holistic approach to weight and health in individuals. “This is a huge step forward and I think it will ultimately lead to better health care and an improved practitioner-patient relationship,” Diewald said. To understand why, one must first understand the history of BMI’s use. The formula that spits out the number we have all come to understand as our BMI considers a person’s height and weight. It was developed in the mid-19th century by a Belgian sociologist to measure the socially ideal person. The modern term and application came about in the 1972 and has been a routine measurement ever since because it is easy, fast, costs nothing and in some cases, said Diewald, does correlate with body fat. But in recent years, large scale studies have exposed some of the limitations of the measure, building to the point where they needed to be weighed against the overt benefits. For starters, BMI does not measure body fat – or adiposity – directly. Adiposity, per Diewald, is more closely associated with health risk than BMI. “For this reason, health risk for some individuals with normal BMI but high body fat has been underestimated, and some with high BMI but normal body fat levels have been overestimated,” she said. Nor does it “differentiate between muscle, bone and body fat, or distribution of fat on the body,” Diewald said. “We know that all these factors can influence health and chronic disease risk.” Other comorbidities or chronic conditions that wouldn’t show up on a BMI chart alongside a number in the “normal” range can also impact health. Conversely, there are health conditions that might be incorrectly assumed just because a BMI is high. “Not every person with a high BMI experiences these chronic conditions, so developing a more holistic approach can lead to better assessment, treatment and outcomes,” Diewald said. Another shortfall she pointed out was its failure to factor in gender, race, body composition, ethnicity or physical activity level. Think back to the origins of the chart, intended to be a social standard created in Europe nearly two hundred years ago. “BMI tables were originally designed in the 1800’s using a population of white men,” Diewald said. “Understandably, at one point in time it was all we had to evaluate weight status, but it may not be accurate to use this standard alone with all groups of people.” These societal, gender and racial/ethnic factors led the AMA to explicitly cite “historical harm, use for racist exclusion and because BMI is based primarily on data collected from previous generations of non-Hispanic white populations” in the new policy on its clinical use. Additionally, the policy addressed the differences in body composition across genders, races and ages that were not being considered. There is also an ignored mental component in its use to diagnose obesity, which can lead to avoidance of doctor visits and, in turn, further physical issues. “Obesity is a multifactorial, complex condition and addressing it with individuals needs to be done with empathy and sensitivity, beginning with how it is measured,” Diewald said. “There are numerous factors influencing weight well beyond simply food intake, physical activity level and BMI, so it is important for practitioners to recognize that and communicate this to patients. “It is extremely difficult for people with higher weight to be told that they have a high BMI and simply need to eat less and move more. When BMI is used as the sole indicator of weight status, this can be psychologically damaging. We know that many who have been told to lose weight simply based on a high BMI may avoid going to the doctors for routine medical visits and skip necessary preventive care.” It will not be easy, she said, to move away from a method used for so long that has been ingrained as a part of a routine medical visit, but Diewald thinks utilization of the tool in conjunction with other assessments is the best way put this new policy to practice. She advocates for measures such as “Using BMI as only one of several indicators of chronic disease risk, asking permission to discuss weight and health risk, [and] using shared decision-making between practitioners and patient to determine course of treatment.” Education is also paramount to proper assessment of weight-related health risks. “Education cannot stop with physicians, however,” she said. “I think this provides an excellent launching pad for enhanced collaboration among health professionals such as dietitians, nurses, nurse practitioners, physician’s assistants and others involved in providing care, nutrition counseling and lifestyle modification support to patients… Doing this can better fine tune recommendations for treatment, leading to improved outcomes.”
Richard G. Cuming Appointed Chief Operating Officer of ChristianaCare
(WILMINGTON, Del. – June 26, 2023) Richard G. Cuming, Ed.D., MSN, RN, NEA-BC, FAAN, has been named ChristianaCare’s chief operating officer (COO). Cuming has been serving as interim COO since the beginning of this calendar year. He joined ChristianaCare in 2016 as the system’s first Chief Nurse Executive. In his role as COO, Cuming oversees the delivery of efficient and fiscally responsible system operations. He also works with other leaders to ensure high-quality and safe patient care. “Ric has been an invaluable asset to ChristianaCare over the past seven years, especially in navigating the many challenges of the COVID-19 pandemic” said Janice E. Nevin, M.D., MPH, ChristianaCare president and chief executive officer. “As leader of our extraordinary, Magnet®-designated nursing staff and president of ChristianaCare HomeHealth, he has improved the lives of patients and caregivers alike. I look forward to him flourishing in this new role.” Prior to coming to ChristianaCare, Cuming oversaw the operations and strategic direction of nursing services, perioperative and emergency services at Einstein Medical Center Philadelphia, Einstein Medical Center Elkins Park, MossRehab, Einstein Center One and Willowcrest, a skilled nursing center. Ric also previously worked at Jackson Health System in Miami as senior vice president and chief nursing executive, and he served as senior vice president and chief administrative officer at Jackson South Community Hospital. Cuming serves on the board of directors of the DAISY Foundation and board of trustees of the Association of Perioperative Registered Nurses Foundation. He was inducted into the American Academy of Nursing and is an alumnus of both the Robert Wood Johnson Foundation Executive Nurse Fellowship Program and the Wharton School of Business General Management Program. Cuming earned his diploma of collegial studies in nursing at John Abbott College in Montreal, his Bachelor of Science in nursing from the University of Ottawa, his Master of Science in nursing at the University of Miami and his doctorate in adult education and human resource development with a minor in advanced nursing administration from Florida International University.
ChristianaCare ranked as 81st best hospital in the United States and the only health system in Delaware to make the list For the fifth consecutive year, ChristianaCare has earned a spot in Newsweek’s exclusive list of the World’s Best Hospitals – United States, recognized for consistently being at the forefront in care, research and innovation. “Receiving this honor year after year is a testament to the work ChristianaCare caregivers do each day to create health together so that every person can flourish,” said ChristianaCare President & CEO Janice E. Nevin, M.D., MPH. “At its core our mission is a simple, yet profound, one. We take care of people. And I am so proud of everyone in this organization for what five-straight years of being called one of the World’s Best Hospitals says about the exceptional quality of the care we provide.” Headquartered in Wilmington, Del., ChristianaCare ranked 81st in the United States in the annual list that ranks 2,300 hospitals in 28 countries. “ChristianaCare has gained a global reputation thanks to our unwavering focus to provide expert, high-quality care,” said Kert Anzilotti, M.D., MBA, chief medical officer at ChristianaCare. “This award belongs to all our caregivers, who continuously seek new knowledge, are true to their word and are committed to delivering exceptional care to every patient we serve.” Compiled by Newsweek and the global data firm Statista, the lists are based on the following data sources: Recommendations from tens of thousands of doctors, health care professionals and managers across the world. The survey asked participants to recommend hospitals in their own country as well as in other countries. The survey did not permit recommendations of the health professional’s own hospital. Patient surveys originating from publicly available data that included areas such as their general satisfaction with the hospital and their satisfaction with their medical care. Hospital quality metrics such as data on the quality of care for specific treatments, data on hygiene measures and patient safety, and data on clinician-patient ratios. The Patient Reported Outcome Measures (PROM) surveys, which are standardized, validated questionnaires completed by patients to measure their well-being and quality of life. The recognition by Newsweek echoes other quality recognitions that ChristianaCare has received during the past 12 months: For the third consecutive year, Healthgrades named ChristianaCare one of America’s 50 Best Hospitals for 2023. Healthgrades also ranked ChristianaCare as one of America’s 50 Best Hospitals for five service lines: cardiac care, coronary intervention, joint replacement, spine surgery and gastrointestinal surgery. For the seventh consecutive year, the College of Healthcare Information Management Executives named ChristianaCare a Most Wired Health Care Technology Leader. U.S. News & World Report rated ChristianaCare as the No. 42 hospital in the nation for obstetrics and gynecology and a High Performing Hospital for Maternity. U.S. News & World Report also rated ChristianaCare as high-performing in orthopedics. For the second consecutive year, Forbes ranked ChristianaCare as one of the Best Employers for Diversity and Inclusion in the United States. The Human Rights Campaign Foundation gave ChristianaCare’s Christiana Hospital and Wilmington Hospital the top score in the Human Rights Campaign Foundation’s most recent Healthcare Equality Index.
Expert comment on new NHS childhood obesity clinics
Dr Duane Mellor, Senior Teaching Fellow, Centre for Health & Society Aston Medical School and Associate Dean Public Engagement is available for comment on new NHS childhood obesity clinics "It would be about supporting the whole person living with obesity alongside their family. It is important that higher body weight is not a choice, but the result of biology and our modern environment. Families and young people need support to make healthier lifestyle choices easier. We need to focus on kind and effective ways to improve health, weight change is just a product when health behaviours change and should not be seen as the only or main aim." For more details contact Nicola Jones Press and Communications Manager 07825 342091 or n.jones6@aston.ac.uk
Aston University wins £1.8m to boost West Midlands low carbon markets
• Aston University and local industry to develop technology to convert organic material into commercially valuable products • Sawdust, diseased trees and dried chicken litter among what can be transformed into sustainable bioproducts • West Midlands companies are invited to join a cluster to develop new low carbon products for growing markets. Aston University is to receive £1.8 million to transform the West Midlands into a powerhouse of low-carbon product development and commercialisation. The University will be building on its existing research facilities to lead the region’s Biochar CleanTech Accelerator as part of the West Midlands Innovation Accelerator. The project was set up with the aim to secure export contracts for low carbon products worth over £200 million, to be made by a regional industrial cluster. It is hoped that the development of a low-carbon business cluster in the West Midlands will open up new domestic and export markets to help rebuild the region’s engineering and manufacturing status. Biochar, a sustainable form of charcoal, can be used as a soil and plant growth enhancer. It stores carbon in the ground, so there are fewer greenhouse gases in the atmosphere. Other products such as oils can be used as low carbon fuels for boilers and engines and the liquid by-product can be used for low carbon weedkiller, fungicide and plant growth. Aston University’s innovative technology is installed at its urban biochar demonstrator in south Birmingham. The project is based on the strengths of the University’s Energy and Bioproducts Research Institute (EBRI) and its Centre for the Circular Economy and Advanced Sustainability (CEAS). Tim Miller, director of engagement at EBRI, said: “This new development has the potential to rebuild product development, engineering and manufacturing in our region. “The project aims to commercialise knowledge, facilities and the results of long-term university research for the benefit of the environment and our regional economy. “Using the University’s existing expertise and facilities we have the potential to launch new technology-based opportunities as they emerge and mature, The Biochar CleanTech Accelerator is part of the West Midlands Innovation Accelerator which was first announced in the government’s 2022 Levelling up White Paper and started this spring. It is funded through a share of a £100m from Innovate UK, to be divided by three regional innovation accelerators over the next two years. Launched by the West Midlands Combined Authority (WMCA) in March 2023, it will target investment on projects enabling new solutions around Medical and Clean Technologies, to further reinforce the region’s position at the frontier of the UK innovation revolution. The University will also play a key role in two other projects in the West Midlands Innovation Accelerator. Companies interested in joining the cluster can get further information at https://www.aston.ac.uk/biochar-cleantech-accelerator or emailing biochar@aston.ac.uk
Program addresses disparities in breast cancer between Black and white women ChristianaCare’s Helen F. Graham Cancer Center & Research Institute is partnering with Susan G. Komen®, the world’s leading breast cancer organization, in an expansion of Komen’s screening and diagnostics program to income-eligible residents of Delaware. Under the program, Delaware women who meet income qualifications will be able to access no-cost breast cancer screening mammograms and necessary diagnostic follow-up tests. Once approved by Susan G. Komen for care, they can select ChristianaCare for services. ChristianaCare is one of 20 health systems nationwide partnering with Susan G. Komen in the program, which seeks to reduce disparities in areas where the breast cancer mortality gap between Black and white women is the greatest. “The Graham Cancer Center is proud of its longstanding partnership with Susan G. Komen to bring breast cancer screenings to our community and to reduce disparities and save lives,” said Nicholas Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute. “This new partnership with Komen is an innovative way that we are stronger together as we continue to reduce barriers to care and help more Delaware women access timely breast imaging and treatment,” he said. “The screening and diagnostics program is critical for individuals who may have been putting off their breast cancer screening due to concerns about cost,” said Nora Katurakes, RN, OCN, manager of the Graham Cancer Center’s Community Outreach & Education program. “Early detection saves lives, and cost should not be a barrier to accessing high-quality health care services for anyone in need. This program seeks to achieve health equity for all.” “Early detection saves lives, and cost should not be a barrier to accessing high-quality health care services for anyone in need,” said Nora Katurakes, RN, OCN, manager of Community Outreach and Education According to the Delaware Division of Public Health, breast cancer is the most common cancer diagnosed among women in Delaware, and Black women are disproportionately more affected by breast cancer than white and Hispanic women and have a higher mortality rate. In addition, Black women in Delaware have among the highest incidence rates in the U.S. of triple negative breast cancer, an aggressive form of the disease that is harder to treat and more likely to return. The Komen screening and diagnostics program is a service provided through the Komen Patient Care Center. Last year, Susan G. Komen provided nearly 3,000 screening and diagnostics services. Komen hopes to serve another 3,000 individuals in 2023. To be eligible for the program, individuals must have a current annual household income at or below 300% of the Federal Poverty Level. For one person that is $43,740. A two-person family must have a $59,160 household income to be eligible. The Tatiana Copeland Breast Center at the Helen F. Graham Cancer Center & Research Institute is one of the few facilities in the region devoted exclusively to breast care, diagnosis and treatment, and was the first center in the state to offer high-definition 3D mammography imaging. About Breast Cancer Screening Screening mammography tests are used to find breast cancer before it causes any warning signs or symptoms. Regular screening tests along with follow-up tests and treatment, if diagnosed, reduce an individual’s chance of dying from breast cancer. Mammography is a test that uses X-rays to create images of the breast. These images are called mammograms. A radiologist trained to read mammograms studies the images and looks for signs of breast cancer. A mammogram may show: No signs of breast cancer. A benign (not cancer) condition or other change that does not suggest cancer. An abnormal finding that needs follow-up tests to rule out cancer. Income eligible people seeking access to a breast cancer screening mammogram or diagnostic service should contact the Komen Breast Care Helpline at 1-877-465-6636 or helpline@komen.org to learn more. Individuals who would like more information about breast cancer screening in Delaware can also call ChristianaCare Community Health Outreach & Education at 302-623-4661.
Health Professions Academic Building on the Armstrong Campus in Savannah Georgia’s only public medical school has received funding approval to open a new four-year campus in Savannah, an expansion that will provide greater access to education and training for medical students and ease the state’s ongoing shortage of physicians. The new campus of Augusta University’s Medical College of Georgia (MCG) is expected to enroll its first students on the Armstrong Campus of Georgia Southern University by Fall 2024, pending approval by the Liaison Committee on Medical Education, the accrediting body for medical schools in the U.S. and Canada. The campus will be located in the existing Armstrong Center and the Health Professions Academic Building of Georgia Southern’s Waters College of Health Professions. Located down the street from Savannah’s St. Joseph’s Hospital, it would be MCG’s third four-year campus in Georgia. The MCG educational experience is anchored at its main campus in Augusta, with another four-year campus located in Athens in partnership with the University of Georgia. “Georgia ranks 40th in the nation for both the number of active physicians and the number of primary care doctors,” Georgia House Speaker Jon Burns said. “Georgians experience this reality every day. Increasing opportunities within the University System of Georgia allows Augusta University’s Medical College of Georgia to educate and train more students and meets a clear need to make sure our communities receive better health care. Georgia needs more doctors, and I’m proud we are making this investment in our future.” The Board of Regents of the University System of Georgia (USG) on Tuesday approved $1.7 million for renovations at Georgia Southern’s Armstrong Campus to help make the new campus a reality. The money was included in the fiscal year 2024 state budget passed earlier this year by the Georgia General Assembly and signed by Gov. Brian Kemp on May 5. “We’re grateful to Governor Kemp, Speaker Burns, Lt. Gov. Jones and the General Assembly for their support in helping MCG and the university system expand one of the best public medical colleges in the nation and help get more doctors into our local communities,” USG Chancellor Sonny Perdue said. Four-year campuses provide the full spectrum of medical education, from basic sciences to clinical experiences. “This campus expansion is a momentous milestone for Augusta University and the Medical College of Georgia, standing as a testament to the unwavering support we have received from Speaker Burns, state Rep. Butch Parrish, Governor Kemp, the entire General Assembly and Chancellor Perdue,” said Augusta University President Brooks A. Keel, PhD. “Through this collaboration, we are forging a brighter future for health care in Georgia and fulfilling our shared commitment to producing more doctors for our state. I extend my deepest gratitude to all those who have championed this vision, including St. Joseph’s/Candler Health System, whose exceptional partnership has provided invaluable clinical experiences for our students. Together, we are bolstering the state’s medical community and strengthening Southeast Georgia’s access to quality health care.” MCG’s statewide educational model also has students learning at two-year, clinically focused regional campuses in every corner of the state, including the Southeast Campus, established in 2011 and based at St. Joseph’s/Candler in Savannah, and Southeast Georgia Health System in Brunswick. Other regional campuses include the Southwest Campus based in Albany and the Northwest Campus based in Rome. “This partnership with Augusta University and the Medical College of Georgia is another example of how together, the governor, our legislators, the University System of Georgia and Georgia Southern University are collaborating to meet the growing needs of Southeast Georgia,” added Georgia Southern University President Kyle Marrero. “These programs on our Savannah campus further Armstrong’s history of being a leader in training health care professionals and complement our efforts to expand nursing education and develop our future physician assistant program.” Through this partnership, Georgia Southern is providing approximately 23,000 square feet of instructional and lab space in its Armstrong Center and the Waters College of Health Professions’ Health Professions Academic Building. This includes 10,000 square feet of dedicated student group workspace and faculty and staff offices and 13,000 square feet of shared anatomy lab and large classroom space. The renovations include the creation of a new anatomy lab within the Health Professions Building, as well as minor renovations and new furniture, fixtures and equipment for the student group workspace and faculty and staff offices. The new campus would allow MCG to accept 40 more students per year, increasing its class size, already one of the nation’s largest, to 304 students per class. “As the state’s only public medical school, it is both our responsibility and commitment to produce more doctors for Georgia, and this growth in our class size is one way we can fulfill what I consider to be our most critical mission” said MCG Dean David Hess, MD. “This expansion would not be possible without the support of Governor Kemp, the Georgia Legislature, the University System of Georgia, Augusta University President Brooks Keel, and our colleagues at Georgia Southern University. I am also thankful for the unwavering support of St. Joseph’s/Candler Health System, including its CEO Paul Hinchey and chief medical officer Dr. Julia Mikell, a 1976 MCG graduate. Physicians and staff at St. Joseph’s/Candler have been exceptional educational partners, serving as a home base for our Southeast Campus, and providing rich clinical experiences for our third- and fourth-year students, for well over a decade. I know that commitment will extend to students at this new four-year campus.” “This is a sentinel event not only for the future of health care in Georgia, but also for Savannah and the region,” added Paul P. Hinchey, president and CEO of St. Joseph’s/Candler. “We have had a great relationship with MCG for more than a decade and our physicians have been instrumental as faculty in teaching third- and fourth-year students in Savannah. SJ/C has also served as a longstanding clinical site for nursing students from Georgia Southern and from the Armstrong campus. Creating a four-year medical school campus in Savannah will strengthen the medical community in Savannah and throughout Southeast Georgia. I want to thank Speaker Burns, Dr. Hess and the University System of Georgia for making this great vision a reality.” “I am excited to help build a campus that will continue MCG’s mission of educating the next generation of physicians,” said Elizabeth Gray, MD, associate dean at MCG’s Southeast Campus, based in Savannah and Brunswick. “I am confident that Georgia Southern will be an exceptional educational partner, and am excited to continue working with the leadership, physicians and staff at our longtime partners St. Joseph’s/Candler to help increase the number of physicians in this area of the state and beyond.” Interested in learning more? For more information about this exciting new development — simply reach out to Georgia Southern's Director of Communications Jennifer Wise at jwise@georgiasouthern.edu to arrange an interview today.
Aston University student and graduate business startup support programme marks 10th year
BSEEN is a collaboration of four Birmingham universities, led by Aston University It has helped over 800 new businesses to launch through intensive startup bootcamps and a network of business mentors An awards dinner was held on 4 May to celebrate a decade in operation. An Aston University student and graduate business startup support programme has celebrated its 10th year in operation. BSEEN, a collaboration of four Birmingham universities led by Aston University, marked a decade of supporting student and graduate entrepreneurs with an awards dinner on 4 May 2023. Mike Bander, an Aston University alumnus and recipient of an honorary doctorate, was guest speaker and gave a keynote speech. The programme has helped over 800 new businesses to launch through 31 intensive startup bootcamps and a network of 85 business mentors. The awards night at Fazeley Studios in Birmingham showcased the student and graduate entrepreneurs supported by BSEEN and the mentors and professional services organisations who have worked to help startups through surgeries, drop-ins and round table discussions. Mike Bandar, international business trainer and speaker and founding partner of Turn Partners, said: “The power of the collective community has changed “I” into “us”. Personal ambition is essential, but the true spirit of entrepreneurship is to unite, collaborate and transform. Diversity gives us strength by not seeing competitors as rivals, but partners.” Professor Zoe Radnor, pro-vice chancellor and executive dean of the College of Business and Social Sciences at Aston University, said: “I have heard so much about BSEEN that was amazing and I am looking forward to supporting young people to achieve their goals despite European funding for the scheme coming to an end.” Paula Whitehouse, deputy dean for enterprise and engagement at Aston University, said: “The programme has delivered a big social and economic impact with businesses ranging from hand-crafted paper goods to medical devices.” Carolyn Keenan, BSEEN project manager, said: “It has been a privilege to be involved with the programme from the beginning.” The eight awards presented during the event went to the following: BSEEN Rising Star Winner: Ruth Mestel and Charis McRoberts, Calathea Arts Highly Commended: Denise Amory-Reid, Amory R Management BSEEN Champion Award Winner: Ben Brophy, Ad Valorem Accountants Highly Commended: Richard Freeman and Jamie Partington, Higgs LLP Award for Technology Winner: Alliyah and Amirah Khan, Our Tied Camel Highly Commended: Safe Queen Team Award for Creative Industries Winner: Morgan Grice, Odd Orange Highly Commended: Andrea Craciun, Sweetest Mango Illustration Award for Innovation Winner: David Akraka, Akreon Technology Highly Commended: Hardeep Randhawa, ProLimbs Award for Social Impact Winner: Cleo Morris, Mission Diverse Highly Commended: Jamaal O’Driscoll, O’D Collective BSEEN Community Award Winner: Shovon Wiggan, Inspire-a-Doll Highly Commended: Janani Prasad, Supabite.com Award for Small Business Growth Winner: Bobby Bradstock, Serenity Psychotherapy Highly Commended: Joseph Housley and Connor Watt, Narce Media and Ben Curtis, Hobby Store Group. To find out more about the BSEEN programme, click here.